Global Opioids Drug Market Insight and Forecast to 2026
The research team projects that the Opioids Drug market size will grow from XXX in 2019 to XXX by 2026, at an estimated CAGR of XX. The base year considered for the study is 2019, and the market size is projected from 2020 to 2026.
The prime objective of this report is to help the user understand the market in terms of its definition, segmentation, market potential, influential trends, and the challenges that the market is facing with 10 major regions and 30 major countries. Deep researches and analysis were done during the preparation of the report. The readers will find this report very helpful in understanding the market in depth. The data and the information regarding the market are taken from reliable sources such as websites, annual reports of the companies, journals, and others and were checked and validated by the industry experts. The facts and data are represented in the report using diagrams, graphs, pie charts, and other pictorial representations. This enhances the visual representation and also helps in understanding the facts much better.
By Market Players:
Teva
Pfizer
Amneal Pharma
Purdue Pharma
Endo
Mallinckrodt
Mylan
J&J
Collegium
INSYS
Hikma
Egalet
By Type
Oxycodone
Hydromorphone
Codeine
Fentanyl
Other
By Application
Pain Relief
Anesthesia
Other
By Regions/Countries:
North America
United States
Canada
Mexico
East Asia
China
Japan
South Korea
Europe
Germany
United Kingdom
France
Italy
South Asia
India
Southeast Asia
Indonesia
Thailand
Singapore
Middle East
Turkey
Saudi Arabia
Iran
Africa
Nigeria
South Africa
Oceania
Australia
South America
Points Covered in The Report
The points that are discussed within the report are the major market players that are involved in the market such as market players, raw material suppliers, equipment suppliers, end users, traders, distributors and etc.
The complete profile of the companies is mentioned. And the capacity, production, price, revenue, cost, gross, gross margin, sales volume, sales revenue, consumption, growth rate, import, export, supply, future strategies, and the technological developments that they are making are also included within the report. This report analyzed 12 years data history and forecast.
The growth factors of the market is discussed in detail wherein the different end users of the market are explained in detail.
Data and information by market player, by region, by type, by application and etc, and custom research can be added according to specific requirements.
The report contains the SWOT analysis of the market. Finally, the report contains the conclusion part where the opinions of the industrial experts are included.
Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements.
The report focuses on Global, Top 10 Regions and Top 50 Countries Market Size of Opioids Drug 2015-2020, and development forecast 2021-2026 including industries, major players/suppliers worldwide and market share by regions, with company and product introduction, position in the market including their market status and development trend by types and applications which will provide its price and profit status, and marketing status & market growth drivers and challenges, with base year as 2019.
Key Indicators Analysed
Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2015-2020 & Sales by Product Types.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2021-2026. Further the report provides break down details about each region & countries covered in the report. Identifying its production, consumption, import & export, sales volume & revenue forecast.
Market Analysis by Product Type: The report covers majority Product Types in the Opioids Drug Industry, including its product specifications by each key player, volume, sales by Volume and Value (M USD).
Market Analysis by Application Type: Based on the Opioids Drug Industry and its applications, the market is further sub-segmented into several major Application of its industry. It provides you with the market size, CAGR & forecast by each industry applications.
Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and Drivers: Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report will provide with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
COVID-19 Impact
Report covers Impact of Coronavirus COVID-19: Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Opioids Drug market in 2020. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor/outdoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
The prime objective of this report is to help the user understand the market in terms of its definition, segmentation, market potential, influential trends, and the challenges that the market is facing with 10 major regions and 30 major countries. Deep researches and analysis were done during the preparation of the report. The readers will find this report very helpful in understanding the market in depth. The data and the information regarding the market are taken from reliable sources such as websites, annual reports of the companies, journals, and others and were checked and validated by the industry experts. The facts and data are represented in the report using diagrams, graphs, pie charts, and other pictorial representations. This enhances the visual representation and also helps in understanding the facts much better.
By Market Players:
Teva
Pfizer
Amneal Pharma
Purdue Pharma
Endo
Mallinckrodt
Mylan
J&J
Collegium
INSYS
Hikma
Egalet
By Type
Oxycodone
Hydromorphone
Codeine
Fentanyl
Other
By Application
Pain Relief
Anesthesia
Other
By Regions/Countries:
North America
United States
Canada
Mexico
East Asia
China
Japan
South Korea
Europe
Germany
United Kingdom
France
Italy
South Asia
India
Southeast Asia
Indonesia
Thailand
Singapore
Middle East
Turkey
Saudi Arabia
Iran
Africa
Nigeria
South Africa
Oceania
Australia
South America
Points Covered in The Report
The points that are discussed within the report are the major market players that are involved in the market such as market players, raw material suppliers, equipment suppliers, end users, traders, distributors and etc.
The complete profile of the companies is mentioned. And the capacity, production, price, revenue, cost, gross, gross margin, sales volume, sales revenue, consumption, growth rate, import, export, supply, future strategies, and the technological developments that they are making are also included within the report. This report analyzed 12 years data history and forecast.
The growth factors of the market is discussed in detail wherein the different end users of the market are explained in detail.
Data and information by market player, by region, by type, by application and etc, and custom research can be added according to specific requirements.
The report contains the SWOT analysis of the market. Finally, the report contains the conclusion part where the opinions of the industrial experts are included.
Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements.
The report focuses on Global, Top 10 Regions and Top 50 Countries Market Size of Opioids Drug 2015-2020, and development forecast 2021-2026 including industries, major players/suppliers worldwide and market share by regions, with company and product introduction, position in the market including their market status and development trend by types and applications which will provide its price and profit status, and marketing status & market growth drivers and challenges, with base year as 2019.
Key Indicators Analysed
Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2015-2020 & Sales by Product Types.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2021-2026. Further the report provides break down details about each region & countries covered in the report. Identifying its production, consumption, import & export, sales volume & revenue forecast.
Market Analysis by Product Type: The report covers majority Product Types in the Opioids Drug Industry, including its product specifications by each key player, volume, sales by Volume and Value (M USD).
Market Analysis by Application Type: Based on the Opioids Drug Industry and its applications, the market is further sub-segmented into several major Application of its industry. It provides you with the market size, CAGR & forecast by each industry applications.
Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and Drivers: Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report will provide with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
COVID-19 Impact
Report covers Impact of Coronavirus COVID-19: Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Opioids Drug market in 2020. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor/outdoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
1 REPORT OVERVIEW
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Opioids Drug Revenue
1.4 Market Analysis by Type
1.4.1 Global Opioids Drug Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Oxycodone
1.4.3 Hydromorphone
1.4.4 Codeine
1.4.5 Fentanyl
1.4.6 Other
1.5 Market by Application
1.5.1 Global Opioids Drug Market Share by Application: 2021-2026
1.5.2 Pain Relief
1.5.3 Anesthesia
1.5.4 Other
1.6 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.6.2 Covid-19 Impact: Commodity Prices Indices
1.6.3 Covid-19 Impact: Global Major Government Policy
1.7 Study Objectives
1.8 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global Opioids Drug Market Perspective (2021-2026)
2.2 Opioids Drug Growth Trends by Regions
2.2.1 Opioids Drug Market Size by Regions: 2015 VS 2021 VS 2026
2.2.2 Opioids Drug Historic Market Size by Regions (2015-2020)
2.2.3 Opioids Drug Forecasted Market Size by Regions (2021-2026)
3 MARKET COMPETITION BY MANUFACTURERS
3.1 Global Opioids Drug Production Capacity Market Share by Manufacturers (2015-2020)
3.2 Global Opioids Drug Revenue Market Share by Manufacturers (2015-2020)
3.3 Global Opioids Drug Average Price by Manufacturers (2015-2020)
4 OPIOIDS DRUG PRODUCTION BY REGIONS
4.1 North America
4.1.1 North America Opioids Drug Market Size (2015-2026)
4.1.2 Opioids Drug Key Players in North America (2015-2020)
4.1.3 North America Opioids Drug Market Size by Type (2015-2020)
4.1.4 North America Opioids Drug Market Size by Application (2015-2020)
4.2 East Asia
4.2.1 East Asia Opioids Drug Market Size (2015-2026)
4.2.2 Opioids Drug Key Players in East Asia (2015-2020)
4.2.3 East Asia Opioids Drug Market Size by Type (2015-2020)
4.2.4 East Asia Opioids Drug Market Size by Application (2015-2020)
4.3 Europe
4.3.1 Europe Opioids Drug Market Size (2015-2026)
4.3.2 Opioids Drug Key Players in Europe (2015-2020)
4.3.3 Europe Opioids Drug Market Size by Type (2015-2020)
4.3.4 Europe Opioids Drug Market Size by Application (2015-2020)
4.4 South Asia
4.4.1 South Asia Opioids Drug Market Size (2015-2026)
4.4.2 Opioids Drug Key Players in South Asia (2015-2020)
4.4.3 South Asia Opioids Drug Market Size by Type (2015-2020)
4.4.4 South Asia Opioids Drug Market Size by Application (2015-2020)
4.5 Southeast Asia
4.5.1 Southeast Asia Opioids Drug Market Size (2015-2026)
4.5.2 Opioids Drug Key Players in Southeast Asia (2015-2020)
4.5.3 Southeast Asia Opioids Drug Market Size by Type (2015-2020)
4.5.4 Southeast Asia Opioids Drug Market Size by Application (2015-2020)
4.6 Middle East
4.6.1 Middle East Opioids Drug Market Size (2015-2026)
4.6.2 Opioids Drug Key Players in Middle East (2015-2020)
4.6.3 Middle East Opioids Drug Market Size by Type (2015-2020)
4.6.4 Middle East Opioids Drug Market Size by Application (2015-2020)
4.7 Africa
4.7.1 Africa Opioids Drug Market Size (2015-2026)
4.7.2 Opioids Drug Key Players in Africa (2015-2020)
4.7.3 Africa Opioids Drug Market Size by Type (2015-2020)
4.7.4 Africa Opioids Drug Market Size by Application (2015-2020)
4.8 Oceania
4.8.1 Oceania Opioids Drug Market Size (2015-2026)
4.8.2 Opioids Drug Key Players in Oceania (2015-2020)
4.8.3 Oceania Opioids Drug Market Size by Type (2015-2020)
4.8.4 Oceania Opioids Drug Market Size by Application (2015-2020)
4.9 South America
4.9.1 South America Opioids Drug Market Size (2015-2026)
4.9.2 Opioids Drug Key Players in South America (2015-2020)
4.9.3 South America Opioids Drug Market Size by Type (2015-2020)
4.9.4 South America Opioids Drug Market Size by Application (2015-2020)
4.10 Rest of the World
4.10.1 Rest of the World Opioids Drug Market Size (2015-2026)
4.10.2 Opioids Drug Key Players in Rest of the World (2015-2020)
4.10.3 Rest of the World Opioids Drug Market Size by Type (2015-2020)
4.10.4 Rest of the World Opioids Drug Market Size by Application (2015-2020)
5 OPIOIDS DRUG CONSUMPTION BY REGION
5.1 North America
5.1.1 North America Opioids Drug Consumption by Countries
5.1.2 United States
5.1.3 Canada
5.1.4 Mexico
5.2 East Asia
5.2.1 East Asia Opioids Drug Consumption by Countries
5.2.2 China
5.2.3 Japan
5.2.4 South Korea
5.3 Europe
5.3.1 Europe Opioids Drug Consumption by Countries
5.3.2 Germany
5.3.3 United Kingdom
5.3.4 France
5.3.5 Italy
5.3.6 Russia
5.3.7 Spain
5.3.8 Netherlands
5.3.9 Switzerland
5.3.10 Poland
5.4 South Asia
5.4.1 South Asia Opioids Drug Consumption by Countries
5.4.2 India
5.4.3 Pakistan
5.4.4 Bangladesh
5.5 Southeast Asia
5.5.1 Southeast Asia Opioids Drug Consumption by Countries
5.5.2 Indonesia
5.5.3 Thailand
5.5.4 Singapore
5.5.5 Malaysia
5.5.6 Philippines
5.5.7 Vietnam
5.5.8 Myanmar
5.6 Middle East
5.6.1 Middle East Opioids Drug Consumption by Countries
5.6.2 Turkey
5.6.3 Saudi Arabia
5.6.4 Iran
5.6.5 United Arab Emirates
5.6.6 Israel
5.6.7 Iraq
5.6.8 Qatar
5.6.9 Kuwait
5.6.10 Oman
5.7 Africa
5.7.1 Africa Opioids Drug Consumption by Countries
5.7.2 Nigeria
5.7.3 South Africa
5.7.4 Egypt
5.7.5 Algeria
5.7.6 Morocco
5.8 Oceania
5.8.1 Oceania Opioids Drug Consumption by Countries
5.8.2 Australia
5.8.3 New Zealand
5.9 South America
5.9.1 South America Opioids Drug Consumption by Countries
5.9.2 Brazil
5.9.3 Argentina
5.9.4 Columbia
5.9.5 Chile
5.9.6 Venezuela
5.9.7 Peru
5.9.8 Puerto Rico
5.9.9 Ecuador
5.10 Rest of the World
5.10.1 Rest of the World Opioids Drug Consumption by Countries
5.10.2 Kazakhstan
6 OPIOIDS DRUG SALES MARKET BY TYPE (2015-2026)
6.1 Global Opioids Drug Historic Market Size by Type (2015-2020)
6.2 Global Opioids Drug Forecasted Market Size by Type (2021-2026)
7 OPIOIDS DRUG CONSUMPTION MARKET BY APPLICATION(2015-2026)
7.1 Global Opioids Drug Historic Market Size by Application (2015-2020)
7.2 Global Opioids Drug Forecasted Market Size by Application (2021-2026)
8 COMPANY PROFILES AND KEY FIGURES IN OPIOIDS DRUG BUSINESS
8.1 Teva
8.1.1 Teva Company Profile
8.1.2 Teva Opioids Drug Product Specification
8.1.3 Teva Opioids Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.2 Pfizer
8.2.1 Pfizer Company Profile
8.2.2 Pfizer Opioids Drug Product Specification
8.2.3 Pfizer Opioids Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.3 Amneal Pharma
8.3.1 Amneal Pharma Company Profile
8.3.2 Amneal Pharma Opioids Drug Product Specification
8.3.3 Amneal Pharma Opioids Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.4 Purdue Pharma
8.4.1 Purdue Pharma Company Profile
8.4.2 Purdue Pharma Opioids Drug Product Specification
8.4.3 Purdue Pharma Opioids Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.5 Endo
8.5.1 Endo Company Profile
8.5.2 Endo Opioids Drug Product Specification
8.5.3 Endo Opioids Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.6 Mallinckrodt
8.6.1 Mallinckrodt Company Profile
8.6.2 Mallinckrodt Opioids Drug Product Specification
8.6.3 Mallinckrodt Opioids Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.7 Mylan
8.7.1 Mylan Company Profile
8.7.2 Mylan Opioids Drug Product Specification
8.7.3 Mylan Opioids Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.8 J&J
8.8.1 J&J Company Profile
8.8.2 J&J Opioids Drug Product Specification
8.8.3 J&J Opioids Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.9 Collegium
8.9.1 Collegium Company Profile
8.9.2 Collegium Opioids Drug Product Specification
8.9.3 Collegium Opioids Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.10 INSYS
8.10.1 INSYS Company Profile
8.10.2 INSYS Opioids Drug Product Specification
8.10.3 INSYS Opioids Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.11 Hikma
8.11.1 Hikma Company Profile
8.11.2 Hikma Opioids Drug Product Specification
8.11.3 Hikma Opioids Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.12 Egalet
8.12.1 Egalet Company Profile
8.12.2 Egalet Opioids Drug Product Specification
8.12.3 Egalet Opioids Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
9 PRODUCTION AND SUPPLY FORECAST
9.1 Global Forecasted Production of Opioids Drug (2021-2026)
9.2 Global Forecasted Revenue of Opioids Drug (2021-2026)
9.3 Global Forecasted Price of Opioids Drug (2015-2026)
9.4 Global Forecasted Production of Opioids Drug by Region (2021-2026)
9.4.1 North America Opioids Drug Production, Revenue Forecast (2021-2026)
9.4.2 East Asia Opioids Drug Production, Revenue Forecast (2021-2026)
9.4.3 Europe Opioids Drug Production, Revenue Forecast (2021-2026)
9.4.4 South Asia Opioids Drug Production, Revenue Forecast (2021-2026)
9.4.5 Southeast Asia Opioids Drug Production, Revenue Forecast (2021-2026)
9.4.6 Middle East Opioids Drug Production, Revenue Forecast (2021-2026)
9.4.7 Africa Opioids Drug Production, Revenue Forecast (2021-2026)
9.4.8 Oceania Opioids Drug Production, Revenue Forecast (2021-2026)
9.4.9 South America Opioids Drug Production, Revenue Forecast (2021-2026)
9.4.10 Rest of the World Opioids Drug Production, Revenue Forecast (2021-2026)
9.5 Forecast by Type and by Application (2021-2026)
9.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2021-2026)
9.5.2 Global Forecasted Consumption of Opioids Drug by Application (2021-2026)
10 CONSUMPTION AND DEMAND FORECAST
10.1 North America Forecasted Consumption of Opioids Drug by Country
10.2 East Asia Market Forecasted Consumption of Opioids Drug by Country
10.3 Europe Market Forecasted Consumption of Opioids Drug by Countriy
10.4 South Asia Forecasted Consumption of Opioids Drug by Country
10.5 Southeast Asia Forecasted Consumption of Opioids Drug by Country
10.6 Middle East Forecasted Consumption of Opioids Drug by Country
10.7 Africa Forecasted Consumption of Opioids Drug by Country
10.8 Oceania Forecasted Consumption of Opioids Drug by Country
10.9 South America Forecasted Consumption of Opioids Drug by Country
10.10 Rest of the world Forecasted Consumption of Opioids Drug by Country
11 MARKETING CHANNEL, DISTRIBUTORS AND CUSTOMERS
11.1 Marketing Channel
11.2 Opioids Drug Distributors List
11.3 Opioids Drug Customers
12 INDUSTRY TRENDS AND GROWTH STRATEGY
12.1 Market Top Trends
12.2 Market Drivers
12.3 Market Challenges
12.4 Porter’s Five Forces Analysis
12.5 Opioids Drug Market Growth Strategy
13 ANALYST'S VIEWPOINTS/CONCLUSIONS
14 APPENDIX
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Disclaimer
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Opioids Drug Revenue
1.4 Market Analysis by Type
1.4.1 Global Opioids Drug Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Oxycodone
1.4.3 Hydromorphone
1.4.4 Codeine
1.4.5 Fentanyl
1.4.6 Other
1.5 Market by Application
1.5.1 Global Opioids Drug Market Share by Application: 2021-2026
1.5.2 Pain Relief
1.5.3 Anesthesia
1.5.4 Other
1.6 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.6.2 Covid-19 Impact: Commodity Prices Indices
1.6.3 Covid-19 Impact: Global Major Government Policy
1.7 Study Objectives
1.8 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global Opioids Drug Market Perspective (2021-2026)
2.2 Opioids Drug Growth Trends by Regions
2.2.1 Opioids Drug Market Size by Regions: 2015 VS 2021 VS 2026
2.2.2 Opioids Drug Historic Market Size by Regions (2015-2020)
2.2.3 Opioids Drug Forecasted Market Size by Regions (2021-2026)
3 MARKET COMPETITION BY MANUFACTURERS
3.1 Global Opioids Drug Production Capacity Market Share by Manufacturers (2015-2020)
3.2 Global Opioids Drug Revenue Market Share by Manufacturers (2015-2020)
3.3 Global Opioids Drug Average Price by Manufacturers (2015-2020)
4 OPIOIDS DRUG PRODUCTION BY REGIONS
4.1 North America
4.1.1 North America Opioids Drug Market Size (2015-2026)
4.1.2 Opioids Drug Key Players in North America (2015-2020)
4.1.3 North America Opioids Drug Market Size by Type (2015-2020)
4.1.4 North America Opioids Drug Market Size by Application (2015-2020)
4.2 East Asia
4.2.1 East Asia Opioids Drug Market Size (2015-2026)
4.2.2 Opioids Drug Key Players in East Asia (2015-2020)
4.2.3 East Asia Opioids Drug Market Size by Type (2015-2020)
4.2.4 East Asia Opioids Drug Market Size by Application (2015-2020)
4.3 Europe
4.3.1 Europe Opioids Drug Market Size (2015-2026)
4.3.2 Opioids Drug Key Players in Europe (2015-2020)
4.3.3 Europe Opioids Drug Market Size by Type (2015-2020)
4.3.4 Europe Opioids Drug Market Size by Application (2015-2020)
4.4 South Asia
4.4.1 South Asia Opioids Drug Market Size (2015-2026)
4.4.2 Opioids Drug Key Players in South Asia (2015-2020)
4.4.3 South Asia Opioids Drug Market Size by Type (2015-2020)
4.4.4 South Asia Opioids Drug Market Size by Application (2015-2020)
4.5 Southeast Asia
4.5.1 Southeast Asia Opioids Drug Market Size (2015-2026)
4.5.2 Opioids Drug Key Players in Southeast Asia (2015-2020)
4.5.3 Southeast Asia Opioids Drug Market Size by Type (2015-2020)
4.5.4 Southeast Asia Opioids Drug Market Size by Application (2015-2020)
4.6 Middle East
4.6.1 Middle East Opioids Drug Market Size (2015-2026)
4.6.2 Opioids Drug Key Players in Middle East (2015-2020)
4.6.3 Middle East Opioids Drug Market Size by Type (2015-2020)
4.6.4 Middle East Opioids Drug Market Size by Application (2015-2020)
4.7 Africa
4.7.1 Africa Opioids Drug Market Size (2015-2026)
4.7.2 Opioids Drug Key Players in Africa (2015-2020)
4.7.3 Africa Opioids Drug Market Size by Type (2015-2020)
4.7.4 Africa Opioids Drug Market Size by Application (2015-2020)
4.8 Oceania
4.8.1 Oceania Opioids Drug Market Size (2015-2026)
4.8.2 Opioids Drug Key Players in Oceania (2015-2020)
4.8.3 Oceania Opioids Drug Market Size by Type (2015-2020)
4.8.4 Oceania Opioids Drug Market Size by Application (2015-2020)
4.9 South America
4.9.1 South America Opioids Drug Market Size (2015-2026)
4.9.2 Opioids Drug Key Players in South America (2015-2020)
4.9.3 South America Opioids Drug Market Size by Type (2015-2020)
4.9.4 South America Opioids Drug Market Size by Application (2015-2020)
4.10 Rest of the World
4.10.1 Rest of the World Opioids Drug Market Size (2015-2026)
4.10.2 Opioids Drug Key Players in Rest of the World (2015-2020)
4.10.3 Rest of the World Opioids Drug Market Size by Type (2015-2020)
4.10.4 Rest of the World Opioids Drug Market Size by Application (2015-2020)
5 OPIOIDS DRUG CONSUMPTION BY REGION
5.1 North America
5.1.1 North America Opioids Drug Consumption by Countries
5.1.2 United States
5.1.3 Canada
5.1.4 Mexico
5.2 East Asia
5.2.1 East Asia Opioids Drug Consumption by Countries
5.2.2 China
5.2.3 Japan
5.2.4 South Korea
5.3 Europe
5.3.1 Europe Opioids Drug Consumption by Countries
5.3.2 Germany
5.3.3 United Kingdom
5.3.4 France
5.3.5 Italy
5.3.6 Russia
5.3.7 Spain
5.3.8 Netherlands
5.3.9 Switzerland
5.3.10 Poland
5.4 South Asia
5.4.1 South Asia Opioids Drug Consumption by Countries
5.4.2 India
5.4.3 Pakistan
5.4.4 Bangladesh
5.5 Southeast Asia
5.5.1 Southeast Asia Opioids Drug Consumption by Countries
5.5.2 Indonesia
5.5.3 Thailand
5.5.4 Singapore
5.5.5 Malaysia
5.5.6 Philippines
5.5.7 Vietnam
5.5.8 Myanmar
5.6 Middle East
5.6.1 Middle East Opioids Drug Consumption by Countries
5.6.2 Turkey
5.6.3 Saudi Arabia
5.6.4 Iran
5.6.5 United Arab Emirates
5.6.6 Israel
5.6.7 Iraq
5.6.8 Qatar
5.6.9 Kuwait
5.6.10 Oman
5.7 Africa
5.7.1 Africa Opioids Drug Consumption by Countries
5.7.2 Nigeria
5.7.3 South Africa
5.7.4 Egypt
5.7.5 Algeria
5.7.6 Morocco
5.8 Oceania
5.8.1 Oceania Opioids Drug Consumption by Countries
5.8.2 Australia
5.8.3 New Zealand
5.9 South America
5.9.1 South America Opioids Drug Consumption by Countries
5.9.2 Brazil
5.9.3 Argentina
5.9.4 Columbia
5.9.5 Chile
5.9.6 Venezuela
5.9.7 Peru
5.9.8 Puerto Rico
5.9.9 Ecuador
5.10 Rest of the World
5.10.1 Rest of the World Opioids Drug Consumption by Countries
5.10.2 Kazakhstan
6 OPIOIDS DRUG SALES MARKET BY TYPE (2015-2026)
6.1 Global Opioids Drug Historic Market Size by Type (2015-2020)
6.2 Global Opioids Drug Forecasted Market Size by Type (2021-2026)
7 OPIOIDS DRUG CONSUMPTION MARKET BY APPLICATION(2015-2026)
7.1 Global Opioids Drug Historic Market Size by Application (2015-2020)
7.2 Global Opioids Drug Forecasted Market Size by Application (2021-2026)
8 COMPANY PROFILES AND KEY FIGURES IN OPIOIDS DRUG BUSINESS
8.1 Teva
8.1.1 Teva Company Profile
8.1.2 Teva Opioids Drug Product Specification
8.1.3 Teva Opioids Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.2 Pfizer
8.2.1 Pfizer Company Profile
8.2.2 Pfizer Opioids Drug Product Specification
8.2.3 Pfizer Opioids Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.3 Amneal Pharma
8.3.1 Amneal Pharma Company Profile
8.3.2 Amneal Pharma Opioids Drug Product Specification
8.3.3 Amneal Pharma Opioids Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.4 Purdue Pharma
8.4.1 Purdue Pharma Company Profile
8.4.2 Purdue Pharma Opioids Drug Product Specification
8.4.3 Purdue Pharma Opioids Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.5 Endo
8.5.1 Endo Company Profile
8.5.2 Endo Opioids Drug Product Specification
8.5.3 Endo Opioids Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.6 Mallinckrodt
8.6.1 Mallinckrodt Company Profile
8.6.2 Mallinckrodt Opioids Drug Product Specification
8.6.3 Mallinckrodt Opioids Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.7 Mylan
8.7.1 Mylan Company Profile
8.7.2 Mylan Opioids Drug Product Specification
8.7.3 Mylan Opioids Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.8 J&J
8.8.1 J&J Company Profile
8.8.2 J&J Opioids Drug Product Specification
8.8.3 J&J Opioids Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.9 Collegium
8.9.1 Collegium Company Profile
8.9.2 Collegium Opioids Drug Product Specification
8.9.3 Collegium Opioids Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.10 INSYS
8.10.1 INSYS Company Profile
8.10.2 INSYS Opioids Drug Product Specification
8.10.3 INSYS Opioids Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.11 Hikma
8.11.1 Hikma Company Profile
8.11.2 Hikma Opioids Drug Product Specification
8.11.3 Hikma Opioids Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.12 Egalet
8.12.1 Egalet Company Profile
8.12.2 Egalet Opioids Drug Product Specification
8.12.3 Egalet Opioids Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
9 PRODUCTION AND SUPPLY FORECAST
9.1 Global Forecasted Production of Opioids Drug (2021-2026)
9.2 Global Forecasted Revenue of Opioids Drug (2021-2026)
9.3 Global Forecasted Price of Opioids Drug (2015-2026)
9.4 Global Forecasted Production of Opioids Drug by Region (2021-2026)
9.4.1 North America Opioids Drug Production, Revenue Forecast (2021-2026)
9.4.2 East Asia Opioids Drug Production, Revenue Forecast (2021-2026)
9.4.3 Europe Opioids Drug Production, Revenue Forecast (2021-2026)
9.4.4 South Asia Opioids Drug Production, Revenue Forecast (2021-2026)
9.4.5 Southeast Asia Opioids Drug Production, Revenue Forecast (2021-2026)
9.4.6 Middle East Opioids Drug Production, Revenue Forecast (2021-2026)
9.4.7 Africa Opioids Drug Production, Revenue Forecast (2021-2026)
9.4.8 Oceania Opioids Drug Production, Revenue Forecast (2021-2026)
9.4.9 South America Opioids Drug Production, Revenue Forecast (2021-2026)
9.4.10 Rest of the World Opioids Drug Production, Revenue Forecast (2021-2026)
9.5 Forecast by Type and by Application (2021-2026)
9.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2021-2026)
9.5.2 Global Forecasted Consumption of Opioids Drug by Application (2021-2026)
10 CONSUMPTION AND DEMAND FORECAST
10.1 North America Forecasted Consumption of Opioids Drug by Country
10.2 East Asia Market Forecasted Consumption of Opioids Drug by Country
10.3 Europe Market Forecasted Consumption of Opioids Drug by Countriy
10.4 South Asia Forecasted Consumption of Opioids Drug by Country
10.5 Southeast Asia Forecasted Consumption of Opioids Drug by Country
10.6 Middle East Forecasted Consumption of Opioids Drug by Country
10.7 Africa Forecasted Consumption of Opioids Drug by Country
10.8 Oceania Forecasted Consumption of Opioids Drug by Country
10.9 South America Forecasted Consumption of Opioids Drug by Country
10.10 Rest of the world Forecasted Consumption of Opioids Drug by Country
11 MARKETING CHANNEL, DISTRIBUTORS AND CUSTOMERS
11.1 Marketing Channel
11.2 Opioids Drug Distributors List
11.3 Opioids Drug Customers
12 INDUSTRY TRENDS AND GROWTH STRATEGY
12.1 Market Top Trends
12.2 Market Drivers
12.3 Market Challenges
12.4 Porter’s Five Forces Analysis
12.5 Opioids Drug Market Growth Strategy
13 ANALYST'S VIEWPOINTS/CONCLUSIONS
14 APPENDIX
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Disclaimer
LIST OF TABLES AND FIGURES
Table 1. Global Opioids Drug Market Share by Type: 2020 VS 2026
Table 2. Oxycodone Features
Table 3. Hydromorphone Features
Table 4. Codeine Features
Table 5. Fentanyl Features
Table 6. Other Features
Table 11. Global Opioids Drug Market Share by Application: 2020 VS 2026
Table 12. Pain Relief Case Studies
Table 13. Anesthesia Case Studies
Table 14. Other Case Studies
Table 21. Commodity Prices-Metals Price Indices
Table 22. Commodity Prices- Precious Metal Price Indices
Table 23. Commodity Prices- Agricultural Raw Material Price Indices
Table 24. Commodity Prices- Food and Beverage Price Indices
Table 25. Commodity Prices- Fertilizer Price Indices
Table 26. Commodity Prices- Energy Price Indices
Table 27. G20+: Economic Policy Responses to COVID-19
Table 28. Opioids Drug Report Years Considered
Table 29. Global Opioids Drug Market Size YoY Growth 2021-2026 (US$ Million)
Table 30. Global Opioids Drug Market Share by Regions: 2021 VS 2026
Table 31. North America Opioids Drug Market Size YoY Growth (2015-2026) (US$ Million)
Table 32. East Asia Opioids Drug Market Size YoY Growth (2015-2026) (US$ Million)
Table 33. Europe Opioids Drug Market Size YoY Growth (2015-2026) (US$ Million)
Table 34. South Asia Opioids Drug Market Size YoY Growth (2015-2026) (US$ Million)
Table 35. Southeast Asia Opioids Drug Market Size YoY Growth (2015-2026) (US$ Million)
Table 36. Middle East Opioids Drug Market Size YoY Growth (2015-2026) (US$ Million)
Table 37. Africa Opioids Drug Market Size YoY Growth (2015-2026) (US$ Million)
Table 38. Oceania Opioids Drug Market Size YoY Growth (2015-2026) (US$ Million)
Table 39. South America Opioids Drug Market Size YoY Growth (2015-2026) (US$ Million)
Table 40. Rest of the World Opioids Drug Market Size YoY Growth (2015-2026) (US$ Million)
Table 41. North America Opioids Drug Consumption by Countries (2015-2020)
Table 42. East Asia Opioids Drug Consumption by Countries (2015-2020)
Table 43. Europe Opioids Drug Consumption by Region (2015-2020)
Table 44. South Asia Opioids Drug Consumption by Countries (2015-2020)
Table 45. Southeast Asia Opioids Drug Consumption by Countries (2015-2020)
Table 46. Middle East Opioids Drug Consumption by Countries (2015-2020)
Table 47. Africa Opioids Drug Consumption by Countries (2015-2020)
Table 48. Oceania Opioids Drug Consumption by Countries (2015-2020)
Table 49. South America Opioids Drug Consumption by Countries (2015-2020)
Table 50. Rest of the World Opioids Drug Consumption by Countries (2015-2020)
Table 51. Teva Opioids Drug Product Specification
Table 52. Pfizer Opioids Drug Product Specification
Table 53. Amneal Pharma Opioids Drug Product Specification
Table 54. Purdue Pharma Opioids Drug Product Specification
Table 55. Endo Opioids Drug Product Specification
Table 56. Mallinckrodt Opioids Drug Product Specification
Table 57. Mylan Opioids Drug Product Specification
Table 58. J&J Opioids Drug Product Specification
Table 59. Collegium Opioids Drug Product Specification
Table 60. INSYS Opioids Drug Product Specification
Table 61. Hikma Opioids Drug Product Specification
Table 62. Egalet Opioids Drug Product Specification
Table 101. Global Opioids Drug Production Forecast by Region (2021-2026)
Table 102. Global Opioids Drug Sales Volume Forecast by Type (2021-2026)
Table 103. Global Opioids Drug Sales Volume Market Share Forecast by Type (2021-2026)
Table 104. Global Opioids Drug Sales Revenue Forecast by Type (2021-2026)
Table 105. Global Opioids Drug Sales Revenue Market Share Forecast by Type (2021-2026)
Table 106. Global Opioids Drug Sales Price Forecast by Type (2021-2026)
Table 107. Global Opioids Drug Consumption Volume Forecast by Application (2021-2026)
Table 108. Global Opioids Drug Consumption Value Forecast by Application (2021-2026)
Table 109. North America Opioids Drug Consumption Forecast 2021-2026 by Country
Table 110. East Asia Opioids Drug Consumption Forecast 2021-2026 by Country
Table 111. Europe Opioids Drug Consumption Forecast 2021-2026 by Country
Table 112. South Asia Opioids Drug Consumption Forecast 2021-2026 by Country
Table 113. Southeast Asia Opioids Drug Consumption Forecast 2021-2026 by Country
Table 114. Middle East Opioids Drug Consumption Forecast 2021-2026 by Country
Table 115. Africa Opioids Drug Consumption Forecast 2021-2026 by Country
Table 116. Oceania Opioids Drug Consumption Forecast 2021-2026 by Country
Table 117. South America Opioids Drug Consumption Forecast 2021-2026 by Country
Table 118. Rest of the world Opioids Drug Consumption Forecast 2021-2026 by Country
Table 119. Opioids Drug Distributors List
Table 120. Opioids Drug Customers List
Table 121. Porter's Five Forces Analysis
Table 122. Key Executives Interviewed
Figure 1. North America Opioids Drug Consumption and Growth Rate (2015-2020)
Figure 2. North America Opioids Drug Consumption Market Share by Countries in 2020
Figure 3. United States Opioids Drug Consumption and Growth Rate (2015-2020)
Figure 4. Canada Opioids Drug Consumption and Growth Rate (2015-2020)
Figure 5. Mexico Opioids Drug Consumption and Growth Rate (2015-2020)
Figure 6. East Asia Opioids Drug Consumption and Growth Rate (2015-2020)
Figure 7. East Asia Opioids Drug Consumption Market Share by Countries in 2020
Figure 8. China Opioids Drug Consumption and Growth Rate (2015-2020)
Figure 9. Japan Opioids Drug Consumption and Growth Rate (2015-2020)
Figure 10. South Korea Opioids Drug Consumption and Growth Rate (2015-2020)
Figure 11. Europe Opioids Drug Consumption and Growth Rate
Figure 12. Europe Opioids Drug Consumption Market Share by Region in 2020
Figure 13. Germany Opioids Drug Consumption and Growth Rate (2015-2020)
Figure 14. United Kingdom Opioids Drug Consumption and Growth Rate (2015-2020)
Figure 15. France Opioids Drug Consumption and Growth Rate (2015-2020)
Figure 16. Italy Opioids Drug Consumption and Growth Rate (2015-2020)
Figure 17. Russia Opioids Drug Consumption and Growth Rate (2015-2020)
Figure 18. Spain Opioids Drug Consumption and Growth Rate (2015-2020)
Figure 19. Netherlands Opioids Drug Consumption and Growth Rate (2015-2020)
Figure 20. Switzerland Opioids Drug Consumption and Growth Rate (2015-2020)
Figure 21. Poland Opioids Drug Consumption and Growth Rate (2015-2020)
Figure 22. South Asia Opioids Drug Consumption and Growth Rate
Figure 23. South Asia Opioids Drug Consumption Market Share by Countries in 2020
Figure 24. India Opioids Drug Consumption and Growth Rate (2015-2020)
Figure 25. Pakistan Opioids Drug Consumption and Growth Rate (2015-2020)
Figure 26. Bangladesh Opioids Drug Consumption and Growth Rate (2015-2020)
Figure 27. Southeast Asia Opioids Drug Consumption and Growth Rate
Figure 28. Southeast Asia Opioids Drug Consumption Market Share by Countries in 2020
Figure 29. Indonesia Opioids Drug Consumption and Growth Rate (2015-2020)
Figure 30. Thailand Opioids Drug Consumption and Growth Rate (2015-2020)
Figure 31. Singapore Opioids Drug Consumption and Growth Rate (2015-2020)
Figure 32. Malaysia Opioids Drug Consumption and Growth Rate (2015-2020)
Figure 33. Philippines Opioids Drug Consumption and Growth Rate (2015-2020)
Figure 34. Vietnam Opioids Drug Consumption and Growth Rate (2015-2020)
Figure 35. Myanmar Opioids Drug Consumption and Growth Rate (2015-2020)
Figure 36. Middle East Opioids Drug Consumption and Growth Rate
Figure 37. Middle East Opioids Drug Consumption Market Share by Countries in 2020
Figure 38. Turkey Opioids Drug Consumption and Growth Rate (2015-2020)
Figure 39. Saudi Arabia Opioids Drug Consumption and Growth Rate (2015-2020)
Figure 40. Iran Opioids Drug Consumption and Growth Rate (2015-2020)
Figure 41. United Arab Emirates Opioids Drug Consumption and Growth Rate (2015-2020)
Figure 42. Israel Opioids Drug Consumption and Growth Rate (2015-2020)
Figure 43. Iraq Opioids Drug Consumption and Growth Rate (2015-2020)
Figure 44. Qatar Opioids Drug Consumption and Growth Rate (2015-2020)
Figure 45. Kuwait Opioids Drug Consumption and Growth Rate (2015-2020)
Figure 46. Oman Opioids Drug Consumption and Growth Rate (2015-2020)
Figure 47. Africa Opioids Drug Consumption and Growth Rate
Figure 48. Africa Opioids Drug Consumption Market Share by Countries in 2020
Figure 49. Nigeria Opioids Drug Consumption and Growth Rate (2015-2020)
Figure 50. South Africa Opioids Drug Consumption and Growth Rate (2015-2020)
Figure 51. Egypt Opioids Drug Consumption and Growth Rate (2015-2020)
Figure 52. Algeria Opioids Drug Consumption and Growth Rate (2015-2020)
Figure 53. Morocco Opioids Drug Consumption and Growth Rate (2015-2020)
Figure 54. Oceania Opioids Drug Consumption and Growth Rate
Figure 55. Oceania Opioids Drug Consumption Market Share by Countries in 2020
Figure 56. Australia Opioids Drug Consumption and Growth Rate (2015-2020)
Figure 57. New Zealand Opioids Drug Consumption and Growth Rate (2015-2020)
Figure 58. South America Opioids Drug Consumption and Growth Rate
Figure 59. South America Opioids Drug Consumption Market Share by Countries in 2020
Figure 60. Brazil Opioids Drug Consumption and Growth Rate (2015-2020)
Figure 61. Argentina Opioids Drug Consumption and Growth Rate (2015-2020)
Figure 62. Columbia Opioids Drug Consumption and Growth Rate (2015-2020)
Figure 63. Chile Opioids Drug Consumption and Growth Rate (2015-2020)
Figure 64. Venezuelal Opioids Drug Consumption and Growth Rate (2015-2020)
Figure 65. Peru Opioids Drug Consumption and Growth Rate (2015-2020)
Figure 66. Puerto Rico Opioids Drug Consumption and Growth Rate (2015-2020)
Figure 67. Ecuador Opioids Drug Consumption and Growth Rate (2015-2020)
Figure 68. Rest of the World Opioids Drug Consumption and Growth Rate
Figure 69. Rest of the World Opioids Drug Consumption Market Share by Countries in 2020
Figure 70. Kazakhstan Opioids Drug Consumption and Growth Rate (2015-2020)
Figure 71. Global Opioids Drug Production Capacity Growth Rate Forecast (2021-2026)
Figure 72. Global Opioids Drug Revenue Growth Rate Forecast (2021-2026)
Figure 73. Global Opioids Drug Price and Trend Forecast (2015-2026)
Figure 74. North America Opioids Drug Production Growth Rate Forecast (2021-2026)
Figure 75. North America Opioids Drug Revenue Growth Rate Forecast (2021-2026)
Figure 76. East Asia Opioids Drug Production Growth Rate Forecast (2021-2026)
Figure 77. East Asia Opioids Drug Revenue Growth Rate Forecast (2021-2026)
Figure 78. Europe Opioids Drug Production Growth Rate Forecast (2021-2026)
Figure 79. Europe Opioids Drug Revenue Growth Rate Forecast (2021-2026)
Figure 80. South Asia Opioids Drug Production Growth Rate Forecast (2021-2026)
Figure 81. South Asia Opioids Drug Revenue Growth Rate Forecast (2021-2026)
Figure 82. Southeast Asia Opioids Drug Production Growth Rate Forecast (2021-2026)
Figure 83. Southeast Asia Opioids Drug Revenue Growth Rate Forecast (2021-2026)
Figure 84. Middle East Opioids Drug Production Growth Rate Forecast (2021-2026)
Figure 85. Middle East Opioids Drug Revenue Growth Rate Forecast (2021-2026)
Figure 86. Africa Opioids Drug Production Growth Rate Forecast (2021-2026)
Figure 87. Africa Opioids Drug Revenue Growth Rate Forecast (2021-2026)
Figure 88. Oceania Opioids Drug Production Growth Rate Forecast (2021-2026)
Figure 89. Oceania Opioids Drug Revenue Growth Rate Forecast (2021-2026)
Figure 90. South America Opioids Drug Production Growth Rate Forecast (2021-2026)
Figure 91. South America Opioids Drug Revenue Growth Rate Forecast (2021-2026)
Figure 92. Rest of the World Opioids Drug Production Growth Rate Forecast (2021-2026)
Figure 93. Rest of the World Opioids Drug Revenue Growth Rate Forecast (2021-2026)
Figure 94. North America Opioids Drug Consumption Forecast 2021-2026
Figure 95. East Asia Opioids Drug Consumption Forecast 2021-2026
Figure 96. Europe Opioids Drug Consumption Forecast 2021-2026
Figure 97. South Asia Opioids Drug Consumption Forecast 2021-2026
Figure 98. Southeast Asia Opioids Drug Consumption Forecast 2021-2026
Figure 99. Middle East Opioids Drug Consumption Forecast 2021-2026
Figure 100. Africa Opioids Drug Consumption Forecast 2021-2026
Figure 101. Oceania Opioids Drug Consumption Forecast 2021-2026
Figure 102. South America Opioids Drug Consumption Forecast 2021-2026
Figure 103. Rest of the world Opioids Drug Consumption Forecast 2021-2026
Figure 104. Channels of Distribution
Figure 105. Distributors Profiles
Table 1. Global Opioids Drug Market Share by Type: 2020 VS 2026
Table 2. Oxycodone Features
Table 3. Hydromorphone Features
Table 4. Codeine Features
Table 5. Fentanyl Features
Table 6. Other Features
Table 11. Global Opioids Drug Market Share by Application: 2020 VS 2026
Table 12. Pain Relief Case Studies
Table 13. Anesthesia Case Studies
Table 14. Other Case Studies
Table 21. Commodity Prices-Metals Price Indices
Table 22. Commodity Prices- Precious Metal Price Indices
Table 23. Commodity Prices- Agricultural Raw Material Price Indices
Table 24. Commodity Prices- Food and Beverage Price Indices
Table 25. Commodity Prices- Fertilizer Price Indices
Table 26. Commodity Prices- Energy Price Indices
Table 27. G20+: Economic Policy Responses to COVID-19
Table 28. Opioids Drug Report Years Considered
Table 29. Global Opioids Drug Market Size YoY Growth 2021-2026 (US$ Million)
Table 30. Global Opioids Drug Market Share by Regions: 2021 VS 2026
Table 31. North America Opioids Drug Market Size YoY Growth (2015-2026) (US$ Million)
Table 32. East Asia Opioids Drug Market Size YoY Growth (2015-2026) (US$ Million)
Table 33. Europe Opioids Drug Market Size YoY Growth (2015-2026) (US$ Million)
Table 34. South Asia Opioids Drug Market Size YoY Growth (2015-2026) (US$ Million)
Table 35. Southeast Asia Opioids Drug Market Size YoY Growth (2015-2026) (US$ Million)
Table 36. Middle East Opioids Drug Market Size YoY Growth (2015-2026) (US$ Million)
Table 37. Africa Opioids Drug Market Size YoY Growth (2015-2026) (US$ Million)
Table 38. Oceania Opioids Drug Market Size YoY Growth (2015-2026) (US$ Million)
Table 39. South America Opioids Drug Market Size YoY Growth (2015-2026) (US$ Million)
Table 40. Rest of the World Opioids Drug Market Size YoY Growth (2015-2026) (US$ Million)
Table 41. North America Opioids Drug Consumption by Countries (2015-2020)
Table 42. East Asia Opioids Drug Consumption by Countries (2015-2020)
Table 43. Europe Opioids Drug Consumption by Region (2015-2020)
Table 44. South Asia Opioids Drug Consumption by Countries (2015-2020)
Table 45. Southeast Asia Opioids Drug Consumption by Countries (2015-2020)
Table 46. Middle East Opioids Drug Consumption by Countries (2015-2020)
Table 47. Africa Opioids Drug Consumption by Countries (2015-2020)
Table 48. Oceania Opioids Drug Consumption by Countries (2015-2020)
Table 49. South America Opioids Drug Consumption by Countries (2015-2020)
Table 50. Rest of the World Opioids Drug Consumption by Countries (2015-2020)
Table 51. Teva Opioids Drug Product Specification
Table 52. Pfizer Opioids Drug Product Specification
Table 53. Amneal Pharma Opioids Drug Product Specification
Table 54. Purdue Pharma Opioids Drug Product Specification
Table 55. Endo Opioids Drug Product Specification
Table 56. Mallinckrodt Opioids Drug Product Specification
Table 57. Mylan Opioids Drug Product Specification
Table 58. J&J Opioids Drug Product Specification
Table 59. Collegium Opioids Drug Product Specification
Table 60. INSYS Opioids Drug Product Specification
Table 61. Hikma Opioids Drug Product Specification
Table 62. Egalet Opioids Drug Product Specification
Table 101. Global Opioids Drug Production Forecast by Region (2021-2026)
Table 102. Global Opioids Drug Sales Volume Forecast by Type (2021-2026)
Table 103. Global Opioids Drug Sales Volume Market Share Forecast by Type (2021-2026)
Table 104. Global Opioids Drug Sales Revenue Forecast by Type (2021-2026)
Table 105. Global Opioids Drug Sales Revenue Market Share Forecast by Type (2021-2026)
Table 106. Global Opioids Drug Sales Price Forecast by Type (2021-2026)
Table 107. Global Opioids Drug Consumption Volume Forecast by Application (2021-2026)
Table 108. Global Opioids Drug Consumption Value Forecast by Application (2021-2026)
Table 109. North America Opioids Drug Consumption Forecast 2021-2026 by Country
Table 110. East Asia Opioids Drug Consumption Forecast 2021-2026 by Country
Table 111. Europe Opioids Drug Consumption Forecast 2021-2026 by Country
Table 112. South Asia Opioids Drug Consumption Forecast 2021-2026 by Country
Table 113. Southeast Asia Opioids Drug Consumption Forecast 2021-2026 by Country
Table 114. Middle East Opioids Drug Consumption Forecast 2021-2026 by Country
Table 115. Africa Opioids Drug Consumption Forecast 2021-2026 by Country
Table 116. Oceania Opioids Drug Consumption Forecast 2021-2026 by Country
Table 117. South America Opioids Drug Consumption Forecast 2021-2026 by Country
Table 118. Rest of the world Opioids Drug Consumption Forecast 2021-2026 by Country
Table 119. Opioids Drug Distributors List
Table 120. Opioids Drug Customers List
Table 121. Porter's Five Forces Analysis
Table 122. Key Executives Interviewed
Figure 1. North America Opioids Drug Consumption and Growth Rate (2015-2020)
Figure 2. North America Opioids Drug Consumption Market Share by Countries in 2020
Figure 3. United States Opioids Drug Consumption and Growth Rate (2015-2020)
Figure 4. Canada Opioids Drug Consumption and Growth Rate (2015-2020)
Figure 5. Mexico Opioids Drug Consumption and Growth Rate (2015-2020)
Figure 6. East Asia Opioids Drug Consumption and Growth Rate (2015-2020)
Figure 7. East Asia Opioids Drug Consumption Market Share by Countries in 2020
Figure 8. China Opioids Drug Consumption and Growth Rate (2015-2020)
Figure 9. Japan Opioids Drug Consumption and Growth Rate (2015-2020)
Figure 10. South Korea Opioids Drug Consumption and Growth Rate (2015-2020)
Figure 11. Europe Opioids Drug Consumption and Growth Rate
Figure 12. Europe Opioids Drug Consumption Market Share by Region in 2020
Figure 13. Germany Opioids Drug Consumption and Growth Rate (2015-2020)
Figure 14. United Kingdom Opioids Drug Consumption and Growth Rate (2015-2020)
Figure 15. France Opioids Drug Consumption and Growth Rate (2015-2020)
Figure 16. Italy Opioids Drug Consumption and Growth Rate (2015-2020)
Figure 17. Russia Opioids Drug Consumption and Growth Rate (2015-2020)
Figure 18. Spain Opioids Drug Consumption and Growth Rate (2015-2020)
Figure 19. Netherlands Opioids Drug Consumption and Growth Rate (2015-2020)
Figure 20. Switzerland Opioids Drug Consumption and Growth Rate (2015-2020)
Figure 21. Poland Opioids Drug Consumption and Growth Rate (2015-2020)
Figure 22. South Asia Opioids Drug Consumption and Growth Rate
Figure 23. South Asia Opioids Drug Consumption Market Share by Countries in 2020
Figure 24. India Opioids Drug Consumption and Growth Rate (2015-2020)
Figure 25. Pakistan Opioids Drug Consumption and Growth Rate (2015-2020)
Figure 26. Bangladesh Opioids Drug Consumption and Growth Rate (2015-2020)
Figure 27. Southeast Asia Opioids Drug Consumption and Growth Rate
Figure 28. Southeast Asia Opioids Drug Consumption Market Share by Countries in 2020
Figure 29. Indonesia Opioids Drug Consumption and Growth Rate (2015-2020)
Figure 30. Thailand Opioids Drug Consumption and Growth Rate (2015-2020)
Figure 31. Singapore Opioids Drug Consumption and Growth Rate (2015-2020)
Figure 32. Malaysia Opioids Drug Consumption and Growth Rate (2015-2020)
Figure 33. Philippines Opioids Drug Consumption and Growth Rate (2015-2020)
Figure 34. Vietnam Opioids Drug Consumption and Growth Rate (2015-2020)
Figure 35. Myanmar Opioids Drug Consumption and Growth Rate (2015-2020)
Figure 36. Middle East Opioids Drug Consumption and Growth Rate
Figure 37. Middle East Opioids Drug Consumption Market Share by Countries in 2020
Figure 38. Turkey Opioids Drug Consumption and Growth Rate (2015-2020)
Figure 39. Saudi Arabia Opioids Drug Consumption and Growth Rate (2015-2020)
Figure 40. Iran Opioids Drug Consumption and Growth Rate (2015-2020)
Figure 41. United Arab Emirates Opioids Drug Consumption and Growth Rate (2015-2020)
Figure 42. Israel Opioids Drug Consumption and Growth Rate (2015-2020)
Figure 43. Iraq Opioids Drug Consumption and Growth Rate (2015-2020)
Figure 44. Qatar Opioids Drug Consumption and Growth Rate (2015-2020)
Figure 45. Kuwait Opioids Drug Consumption and Growth Rate (2015-2020)
Figure 46. Oman Opioids Drug Consumption and Growth Rate (2015-2020)
Figure 47. Africa Opioids Drug Consumption and Growth Rate
Figure 48. Africa Opioids Drug Consumption Market Share by Countries in 2020
Figure 49. Nigeria Opioids Drug Consumption and Growth Rate (2015-2020)
Figure 50. South Africa Opioids Drug Consumption and Growth Rate (2015-2020)
Figure 51. Egypt Opioids Drug Consumption and Growth Rate (2015-2020)
Figure 52. Algeria Opioids Drug Consumption and Growth Rate (2015-2020)
Figure 53. Morocco Opioids Drug Consumption and Growth Rate (2015-2020)
Figure 54. Oceania Opioids Drug Consumption and Growth Rate
Figure 55. Oceania Opioids Drug Consumption Market Share by Countries in 2020
Figure 56. Australia Opioids Drug Consumption and Growth Rate (2015-2020)
Figure 57. New Zealand Opioids Drug Consumption and Growth Rate (2015-2020)
Figure 58. South America Opioids Drug Consumption and Growth Rate
Figure 59. South America Opioids Drug Consumption Market Share by Countries in 2020
Figure 60. Brazil Opioids Drug Consumption and Growth Rate (2015-2020)
Figure 61. Argentina Opioids Drug Consumption and Growth Rate (2015-2020)
Figure 62. Columbia Opioids Drug Consumption and Growth Rate (2015-2020)
Figure 63. Chile Opioids Drug Consumption and Growth Rate (2015-2020)
Figure 64. Venezuelal Opioids Drug Consumption and Growth Rate (2015-2020)
Figure 65. Peru Opioids Drug Consumption and Growth Rate (2015-2020)
Figure 66. Puerto Rico Opioids Drug Consumption and Growth Rate (2015-2020)
Figure 67. Ecuador Opioids Drug Consumption and Growth Rate (2015-2020)
Figure 68. Rest of the World Opioids Drug Consumption and Growth Rate
Figure 69. Rest of the World Opioids Drug Consumption Market Share by Countries in 2020
Figure 70. Kazakhstan Opioids Drug Consumption and Growth Rate (2015-2020)
Figure 71. Global Opioids Drug Production Capacity Growth Rate Forecast (2021-2026)
Figure 72. Global Opioids Drug Revenue Growth Rate Forecast (2021-2026)
Figure 73. Global Opioids Drug Price and Trend Forecast (2015-2026)
Figure 74. North America Opioids Drug Production Growth Rate Forecast (2021-2026)
Figure 75. North America Opioids Drug Revenue Growth Rate Forecast (2021-2026)
Figure 76. East Asia Opioids Drug Production Growth Rate Forecast (2021-2026)
Figure 77. East Asia Opioids Drug Revenue Growth Rate Forecast (2021-2026)
Figure 78. Europe Opioids Drug Production Growth Rate Forecast (2021-2026)
Figure 79. Europe Opioids Drug Revenue Growth Rate Forecast (2021-2026)
Figure 80. South Asia Opioids Drug Production Growth Rate Forecast (2021-2026)
Figure 81. South Asia Opioids Drug Revenue Growth Rate Forecast (2021-2026)
Figure 82. Southeast Asia Opioids Drug Production Growth Rate Forecast (2021-2026)
Figure 83. Southeast Asia Opioids Drug Revenue Growth Rate Forecast (2021-2026)
Figure 84. Middle East Opioids Drug Production Growth Rate Forecast (2021-2026)
Figure 85. Middle East Opioids Drug Revenue Growth Rate Forecast (2021-2026)
Figure 86. Africa Opioids Drug Production Growth Rate Forecast (2021-2026)
Figure 87. Africa Opioids Drug Revenue Growth Rate Forecast (2021-2026)
Figure 88. Oceania Opioids Drug Production Growth Rate Forecast (2021-2026)
Figure 89. Oceania Opioids Drug Revenue Growth Rate Forecast (2021-2026)
Figure 90. South America Opioids Drug Production Growth Rate Forecast (2021-2026)
Figure 91. South America Opioids Drug Revenue Growth Rate Forecast (2021-2026)
Figure 92. Rest of the World Opioids Drug Production Growth Rate Forecast (2021-2026)
Figure 93. Rest of the World Opioids Drug Revenue Growth Rate Forecast (2021-2026)
Figure 94. North America Opioids Drug Consumption Forecast 2021-2026
Figure 95. East Asia Opioids Drug Consumption Forecast 2021-2026
Figure 96. Europe Opioids Drug Consumption Forecast 2021-2026
Figure 97. South Asia Opioids Drug Consumption Forecast 2021-2026
Figure 98. Southeast Asia Opioids Drug Consumption Forecast 2021-2026
Figure 99. Middle East Opioids Drug Consumption Forecast 2021-2026
Figure 100. Africa Opioids Drug Consumption Forecast 2021-2026
Figure 101. Oceania Opioids Drug Consumption Forecast 2021-2026
Figure 102. South America Opioids Drug Consumption Forecast 2021-2026
Figure 103. Rest of the world Opioids Drug Consumption Forecast 2021-2026
Figure 104. Channels of Distribution
Figure 105. Distributors Profiles
